| 引用本文：赵明月, 吴晶.常用低价药品清单及其在天津市的使用情况分析[J].中国卫生政策研究,2014,7(11):13-18 |
|
| 常用低价药品清单及其在天津市的使用情况分析 |
| 投稿时间：2014-09-18 修订日期：2014-10-13 PDF全文浏览 HTML全文浏览 |
| 赵明月, 吴晶 |
| 天津大学药物科学与技术学院 天津 300072 |
| 摘要:目的:掌握国家常用低价药清单基本情况及其在天津市的使用情况,为后续政策的进一步完善提供决策参考。方法:采用《国家基本药物目录》、《国家基本医疗保险、工伤保险和生育保险药品目录》以及国家发展改革委发布的“低价药清单”、按照是否独家品种、治疗领域等分类原则,对常用低价药清单进行分析。利用天津市城镇职工基本医疗保险数据库,分析2008—2011年天津市低价药品使用情况。结果:低价药清单涵盖了西药19个治疗类别、中成药8个治疗类别。以通用名计,低价药清单与基本药物目录重合度为54.1%,全部来源于医保目录。低价药清单中独家品种41个,独家品种剂型149个。2008—2011年天津市低价西药费用占西药总费用平均比例为4.7%,低价中成药费用占中成药总费用比例为11.0%,并且均呈现逐年上涨的趋势。低价药清单中基本药物、独家品种剂型费用占比逐年增加,独家品种费用占比逐年下降。结论:低价药清单中独家品种和独家品种剂型较多,应密切关注这些品种的价格变化趋势。天津市三级医疗机构和零售药店低价药费用占比较低。建议:应尽快落实医疗机构常用短缺低价药品报告制度,推进医保总额预算制度,促进低价药品的使用,并不断提高零售药店销售低价药品积极性。 |
| 关键词:低价药品 费用比例 独家品种 |
| 基金项目:国家自然科学基金(71203155) |
|
| Analysis on national list of common low-price medicine and medicine sales in Tianjin |
| ZHAO Ming-yue, WU Jing |
| School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China |
| Abstract:Objective: To get the basic situation of the list of low-price medicines and their sales in Tianjin to provide future policy reference. Methods: The low-price medicine list was analyzed through different principles of classification including the National Essential medicine List (NEML), National Reimbursement medicine List (NRML) and exclusive production. The study analyzed the sales status of the low-price medicines in the Tianjin from 2008 to 2011 using the Tianjin Urban Employee Basic Medical Insurance (UEBMI) database. Results: 19 classes of chemical medicines and eight classes of traditional Chinese Medicine are included in the low-price medicine list. All of the medicines in the low-price list come from the NRML, and the replication ratio between the NEML and the low-price medicine list is 54.1%. There are 41 exclusive productions and 149 exclusive formulation productions. From 2008 to 2011, the average ratio of the chemical low-price medicines and traditional Chinese Medicine sales to total medicines sales are 4.7% and 11.0%, respectively. Both national essential medicines and exclusive formulation production sales ratios are increasing, however the sales ratio of exclusive production decreased from 2008 to 2011. Conclusion: The government should pay greater attention to the supply and production of the list's exclusive production. The sales ratio of low-price medicines to total medicines sales is much lower in the retail pharmacies and tertiary medical institutions than other medical institutions. Suggestions: The government should practice the shortage report system of common low-price medicine as soon as possible, with efforts made to implement the global budgeting policy and encourage sales enthusiasm for low-price medicines in retail pharmacies. |
| Key words:Low-price medicine Expense ratio Exclusive varieties |
| 摘要点击次数: 2363 全文下载次数: 1306 |
|
|
|
|
|
